Lifecore Biomedical Inc. (LFCR) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $7.37
• Market Cap: $274.63M
• EPS: $-1.27
• 52-Week High: $8.98
• 52-Week Low: $4.76

Market Sentiment

Lifecore Biomedical Inc. currently has a Neutral sentiment score of -0.01.

About Lifecore Biomedical Inc.

Lifecore Biomedical Inc. (LFCR) is a leading integrated contract development and manufacturing organization located in Santa Maria, California, renowned for its expertise in formulating and producing complex biopharmaceuticals and medical devices. Leveraging advanced technologies and extensive industry knowledge, the company provides high-quality, tailored solutions to a diverse clientele, both domestically and internationally. Committed to innovation and precision, Lifecore is strategically ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Lifecore Biomedical Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LFCR pay dividends?

Lifecore Biomedical Inc. (LFCR) does not currently pay a regular dividend.

What is LFCR's market cap?

Lifecore Biomedical Inc. (LFCR) has a market capitalization of $274.63M with a current stock price of $7.37.